ReutersWest Virginia abortion ban cannot block use of pills, GenBioPro tells court
- Bias Rating
-16% Somewhat Liberal
- Reliability
70% ReliableGood
- Policy Leaning
-16% Somewhat Liberal
- Politician Portrayal
-58% Negative
Continue For Free
Create your free account to see the in-depth bias analytics and more.
Continue
Continue
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates. Already a member: Log inBias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
7% Positive
- Liberal
- Conservative
| Sentence | Sentiment | Bias |
|---|---|---|
Unlock this feature by upgrading to the Pro plan. | ||
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Contributing sentiments towards policy:
59% : Mifepristone is at the center of another high-profile lawsuit brought in 2022 in Texas by anti-abortion groups seeking to undo the drug's FDA approval, who are also represented by the Alliance Defending Freedom.52% : The case is GenBioPro v. Raynes, 4th U.S. Circuit Court of Appeals, No. 23-2194.
47% : Circuit Judge J. Harvie Wilkinson said federal regulation was a floor, not a ceiling, for state regulation of drugs, and that states had the right to go further.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.